- Home
- DSWL vs CGTX Comparison
DSWL vs CGTX Comparison
Compare DSWL & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSWL
- CGTX
- Stock Information
- Founded
- DSWL 1987
- CGTX 2007
- Country
- DSWL Macau
- CGTX United States
- Employees
- DSWL N/A
- CGTX N/A
- Industry
- DSWL Plastic Products
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- DSWL Industrials
- CGTX Health Care
- Exchange
- DSWL Nasdaq
- CGTX Nasdaq
- Market Cap
- DSWL 64.1M
- CGTX 53.4M
- IPO Year
- DSWL 1995
- CGTX 2021
- Fundamental
- Price
- DSWL $4.03
- CGTX $1.47
- Analyst Decision
- DSWL
- CGTX Strong Buy
- Analyst Count
- DSWL 0
- CGTX 3
- Target Price
- DSWL N/A
- CGTX $2.83
- AVG Volume (30 Days)
- DSWL 43.3K
- CGTX 7.6M
- Earning Date
- DSWL 11-14-2025
- CGTX 11-12-2025
- Dividend Yield
- DSWL 4.95%
- CGTX N/A
- EPS Growth
- DSWL 45.62
- CGTX N/A
- EPS
- DSWL 0.70
- CGTX N/A
- Revenue
- DSWL $67,610,000.00
- CGTX N/A
- Revenue This Year
- DSWL N/A
- CGTX N/A
- Revenue Next Year
- DSWL N/A
- CGTX N/A
- P/E Ratio
- DSWL $5.67
- CGTX N/A
- Revenue Growth
- DSWL N/A
- CGTX N/A
- 52 Week Low
- DSWL $1.93
- CGTX $0.22
- 52 Week High
- DSWL $4.48
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- DSWL 58.98
- CGTX 39.92
- Support Level
- DSWL $3.80
- CGTX $1.44
- Resistance Level
- DSWL $4.40
- CGTX $2.60
- Average True Range (ATR)
- DSWL 0.21
- CGTX 0.29
- MACD
- DSWL -0.05
- CGTX -0.19
- Stochastic Oscillator
- DSWL 37.50
- CGTX 3.23
About DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.